Hans Barella, member of the board of directors Elekta AB, Sweden, Chairman of the supervisory board of SupersonicImagine SA, France and the new chairman of the Sapiens Board of Directors, said: "I am looking forward to working with such an entrepreneurial team as well as with this group of reputable investors on this exciting technology that has the potential to improve brain stimulation therapy for patients with Parkinson's Disease as well as other neurological and psychiatric indications."
Todd Whitehurst, MD, VP Product Development, Sensors for Medicine and Science, Inc (SMSI), a California-based implantable sensor company, comments: "The Sapiens system is a dramatic leap forward in neuromodulation technology. With the Sapiens system, patients will receive optimal therapy with fewer side effects. The expected reductions in surgery duration and programming time represent a significant improvement for neurosurgeons and neurologists as well as patients."
Ad Statistics
Times Displayed: 113476
Times Visited: 6766 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Regina Hodits, from Wellington Partners: "Sapiens' integrated approach of steering neuro modulation not only offers significant advantages to patients, physicians and payors, but the advanced stage of the technology, based upon significant developments within Philips Research, also makes it an attractive investment opportunity. We are very much looking forward to working with the Sapiens' team on making Sapiens a success. "
Olivier Litzka, from Edmond de Rothschild Investment Partners: "Sapiens' complete solution has the potential to significantly expand the use of DBS by simplifying the surgical procedure and by greatly improving efficacy and safety. We are excited to back the development of this ambitious project and this great team."
About Sapiens
Sapiens Brain Steering Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI-compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies. For more information, please visit www.sapiensneuro.com.
About Sapiens proprietary DBS system
Sapiens is developing a unique, high-resolution, and MRI-compatible DBS system comprising navigation and steering software and implants. The software solution creates a patient specific brain map and will support the surgeon in finding the ideal trajectory, avoiding critical structures en route to the target zone. It will also allow a faster, accurate placement of electrodes in the target area of the brain. Sapiens' probe will be an array with many tiny electrodes that can be activated independently allowing to precisely steer the stimulation pulses to desired target regions. The image-based software allows the optimization of steering the current to its desired position and enabling further programming and post-operative fine tuning. Sapiens complete solution includes next-generation implantable pulse generators (IPG) with superior MRI-compatibility features and battery life.
